141 related articles for article (PubMed ID: 23797068)
1. Full functional activity of SSL7 requires binding of both complement C5 and IgA.
Lorenz N; Clow F; Radcliff FJ; Fraser JD
Immunol Cell Biol; 2013 Aug; 91(7):469-76. PubMed ID: 23797068
[TBL] [Abstract][Full Text] [Related]
2. Functional basis for complement evasion by staphylococcal superantigen-like 7.
Bestebroer J; Aerts PC; Rooijakkers SH; Pandey MK; Köhl J; van Strijp JA; de Haas CJ
Cell Microbiol; 2010 Oct; 12(10):1506-16. PubMed ID: 20545943
[TBL] [Abstract][Full Text] [Related]
3. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
Laursen NS; Gordon N; Hermans S; Lorenz N; Jackson N; Wines B; Spillner E; Christensen JB; Jensen M; Fredslund F; Bjerre M; Sottrup-Jensen L; Fraser JD; Andersen GR
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3681-6. PubMed ID: 20133685
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Ramsland PA; Willoughby N; Trist HM; Farrugia W; Hogarth PM; Fraser JD; Wines BD
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15051-6. PubMed ID: 17848512
[TBL] [Abstract][Full Text] [Related]
6. Identification of Set11 from Staphylococcus aureus Mu50 strain as a ortholog of SSL7 via bioinformatic analysis and determination of its possible targets from human serum using CNBr-pull down assays.
Li Y; Chen X; Jia N; Zhang X; Zang J
Biotechnol Lett; 2017 Sep; 39(9):1413-1423. PubMed ID: 28653102
[TBL] [Abstract][Full Text] [Related]
7. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
Wines BD; Willoughby N; Fraser JD; Hogarth PM
J Biol Chem; 2006 Jan; 281(3):1389-93. PubMed ID: 16293625
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.
Li Y; Clow F; Fraser JD; Lin F
J Mol Med (Berl); 2018 Sep; 96(9):965-974. PubMed ID: 30066197
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.
Wines BD; Ramsland PA; Trist HM; Gardam S; Brink R; Fraser JD; Hogarth PM
J Biol Chem; 2011 Sep; 286(38):33118-24. PubMed ID: 21784854
[TBL] [Abstract][Full Text] [Related]
10. A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the
Yatime L; Merle NS; Hansen AG; Friis NA; Østergaard JA; Bjerre M; Roumenina LT; Thiel S; Kristensen P; Andersen GR
Front Immunol; 2018; 9():2822. PubMed ID: 30555486
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcal enterotoxin-like X (SElX) is a unique superantigen with functional features of two major families of staphylococcal virulence factors.
Langley RJ; Ting YT; Clow F; Young PG; Radcliff FJ; Choi JM; Sequeira RP; Holtfreter S; Baker H; Fraser JD
PLoS Pathog; 2017 Sep; 13(9):e1006549. PubMed ID: 28880913
[TBL] [Abstract][Full Text] [Related]
12. The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo.
Koymans KJ; Goldmann O; Karlsson CAQ; Sital W; Thänert R; Bisschop A; Vrieling M; Malmström J; van Kessel KPM; de Haas CJC; van Strijp JAG; Medina E
J Innate Immun; 2017; 9(6):561-573. PubMed ID: 28858870
[TBL] [Abstract][Full Text] [Related]
13. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
14. Epic Immune Battles of History: Neutrophils vs.
Guerra FE; Borgogna TR; Patel DM; Sward EW; Voyich JM
Front Cell Infect Microbiol; 2017; 7():286. PubMed ID: 28713774
[TBL] [Abstract][Full Text] [Related]
15. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.
Laursen NS; Andersen KR; Braren I; Spillner E; Sottrup-Jensen L; Andersen GR
EMBO J; 2011 Feb; 30(3):606-16. PubMed ID: 21217642
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal complement evasion by various convertase-blocking molecules.
Jongerius I; Köhl J; Pandey MK; Ruyken M; van Kessel KP; van Strijp JA; Rooijakkers SH
J Exp Med; 2007 Oct; 204(10):2461-71. PubMed ID: 17893203
[TBL] [Abstract][Full Text] [Related]
17. Serine-Aspartate Repeat Protein D Increases Staphylococcus aureus Virulence and Survival in Blood.
Askarian F; Uchiyama S; Valderrama JA; Ajayi C; Sollid JUE; van Sorge NM; Nizet V; van Strijp JAG; Johannessen M
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795358
[TBL] [Abstract][Full Text] [Related]
18. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
Abi-Rached L; Dorighi K; Norman PJ; Yawata M; Parham P
J Immunol; 2007 Jun; 178(12):7943-54. PubMed ID: 17548632
[TBL] [Abstract][Full Text] [Related]
19. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
